Treatment-Resistant Panic Disorder
The DOI matches its Crossref record; 169 of the 174 references it cites were found in a registry or an index.
Abstract
A substantial number of patients with panic disorder and agoraphobia may remain symptomatic after standard treatment (including selective serotonin reuptake inhibitors, tricyclic antidepressants, benzodiazepines, or irreversible monamine oxidase inhibitors). In this review, recommendations for the treatment of patients with panic disorder and agoraphobia who do not respond to these drugs are provided. Nonresponse to drug treatment could be defined as a failure to achieve a 50% reduction on a standard rating scale after a minimum of 6 weeks of treatment in adequate dose. When initial treatments have failed, the medication should be changed to other standard treatments. In further attempts at treatment, drugs should be used that have shown promising results in preliminary studies, such as venlafaxine. Combination treatments may be used, such as the combination of an selective serotonin reuptake inhibitor and a benzodiazepine. Psychological treatments such as cognitive-behavioral therapy have to be considered in all patients, regardless whether they are nonresponders or not. According to existing studies, a combination of pharmacologic treatment with cognitive-behavioral therapy can be recommended.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in clinical settings, approximately 20–40% of patients did not achieve full remission with the recommended drugs or CBT [10–12]”
From Management of Treatment-Resistant Panic Disorder (2017) · cites this paper as [10]
Citations
Cites
(1985) · Cited by 2,882
Anxiety Disorders and Phobias: A Cognitive Perspective
Dietch, J. T. (1986) · Psychosomatics · doi:10.1016/s0033-3182(86)72726-6 · Cited by 1,505
Multicenter Collaborative Panic Disorder Severity Scale
Shear, M. K., Brown, T. A., Barlow, D. H., Money, R., Sholomskas, D. E., Woods, S. W., Gorman, J. M., & Papp, L. A. (1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.11.1571 · Cited by 1,001
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Delineation of two drug-responsive anxiety syndromes
Klein, D. F. (1964) · Psychopharmacologia · doi:10.1007/bf02193476 · Cited by 898
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Self-citationTreatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms
Sheehan, D. V. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780140053006 · Cited by 729
Clark, D. M., Salkovskis, P. M., Hackmann, A., Middleton, H., Anastasiades, P., & Gelder, M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.759 · Cited by 673
Behavioral treatment of panic disorder
Barlow, D. H., Craske, M. G., Cerny, J. A., & Klosko, J. S. (1989) · Behavior Therapy · doi:10.1016/s0005-7894(89)80073-5 · Cited by 627
Ballenger, J. C. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800290027004 · Cited by 564
Research works printed but not linked: 14
- Mavissakalian, 1983, Agoraphobia: behavioral and pharmacological treatment (n=49), Psychopharmacol Bull, 19, 116
- 1991, International Classification of Diseases
- Barlow, 1994, Treatment of panic disor-der. A consensus development conference, 105
- 10.1002/(sici)1099-1077(199908)14:6<435::aid-hup109>3.0.co;2-b · doi:10.1002/(sici)1099-1077(199908)14:6<435::aid-hup109>3.0.co;2-b
- 10.1016/s0005-7894(05)80266-7 · DOI · Paper page
- 10.3109/10401239909147053 · doi:10.3109/10401239909147053
- 10.1037/0022-006x.68.6.947 · doi:10.1037/0022-006x.68.6.947 · Paper page
- 10.1037/0022-006x.68.1.13 · DOI · Paper page
- 10.1034/j.1600-0447.2001.00263.x · DOI · Paper page
- 10.1037/0022-006x.62.4.865 · DOI · Paper page
- 10.1001/archpsyc.1983.01790020047004 · DOI · Paper page
- 10.1037/0022-006x.65.6.1026 · doi:10.1037/0022-006x.65.6.1026
- 1994, Diagnostic and Statistical Manual of Mental Disorders
- 10.1037/0022-006x.63.5.823 · doi:10.1037/0022-006x.63.5.823 · Paper page
Cited by
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Self-citationBaldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders
Ipser, J. C., Carey, P., Dhansay, Y., Fakier, N., Seedat, S., & Stein, D. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005473.pub2 · Cited by 93
Ori, R., Amos, T., Bergman, H., Soares-Weiser, K., Ipser, J. C., & Stein, D. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007803.pub2 · Cited by 92
Mantovani, A., Lisanby, S. H., Pieraccini, F., Ulivelli, M., Castrogiovanni, P., & Rossi, S. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.11.027 · Cited by 82
“A clinically significant and sustained improvement of panic symptoms was observed in more than 80% of patients, similar to that reported with conventional treatments (Bandelow and Ruther, 2004).”
Result
Metadata
- Authors
- Bandelow, B., & Rüther, E.
- Affiliations
- University of Göttingen (DE)
- ORCID
- Bandelow, Borwin
- Venue
- CNS Spectrums
- Publisher
- Cambridge University Press (CUP)
- Published
- 2004-10
- Volume
- 9
- Issue
- 10
- Pages
- 725-739
- ISSN
- 1092-8529 (ISSN-L)
- 2165-6509
- OpenAlex
- W2242812184
- Semantic Scholar
- 90118a5a1f3484702c3d0fe4b91228d6eb189a1e
- Cited by
- 57
- References
- 174
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 3 · 2021: 3 · 2017: 2 · 2015: 5 · 2014: 1 · 2013: 2 · 2012: 9
- FWCI
- 0.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CNS Spectrums (publishedVersion)
- PubMed (publishedVersion)
- GRO (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Keywords
- panic disorder, agoraphobia, treatment-resistant depression, venlafaxine, selective serotonin reuptake inhibitors, benzodiazepines, tricyclic antidepressants, combination pharmacotherapy, cognitive behavioral therapy, psychological intervention
- MeSH terms
- Antidepressive Agents, Tricyclic, Benzodiazepines, Brain, Combined Modality Therapy, Drug Administration Schedule, Drug Resistance, Humans, Monoamine Oxidase Inhibitors, Exercise, Cognitive Behavioral Therapy, Panic Disorder
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment-Resistant Panic Disorder. https://app.cochat.ai/papers/10.1017/s1092852900022379
- The paper
- Bandelow, B., & Rüther, E. (2004). Treatment-Resistant Panic Disorder. CNS Spectrums. https://doi.org/10.1017/s1092852900022379
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.